These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32492952)

  • 61. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
    K B; V T; N P; M M; N M; F A
    Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.
    Rothman RB; Glowa JR
    Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exercise exerts an anxiolytic effect against repeated restraint stress through 5-HT
    Leem YH; Jang JH; Park JS; Kim HS
    Psychoneuroendocrinology; 2019 Oct; 108():182-189. PubMed ID: 31248747
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses.
    Wu N; Feng Z; He X; Kwon W; Wang J; Xie XQ
    Sci Rep; 2019 Feb; 9(1):2268. PubMed ID: 30783122
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats.
    Tournier BB; Dimiziani A; Tsartsalis S; Millet P; Ginovart N
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29265497
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adenosine and related drugs in brain diseases: present and future in clinical trials.
    Lopes LV; Sebastião AM; Ribeiro JA
    Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adenosine A
    Real JI; Simões AP; Cunha RA; Ferreira SG; Rial D
    Eur J Neurosci; 2018 May; 47(9):1127-1134. PubMed ID: 29570875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
    Le Foll B; Goldberg SR
    J Pharmacol Exp Ther; 2005 Mar; 312(3):875-83. PubMed ID: 15525797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
    Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
    J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chronic oral administration of MPEP, an antagonist of mGlu
    López-Zapata A; León-Navarro DA; Crespo M; Albasanz JL; Martín M
    Neuroscience; 2017 Mar; 344():187-203. PubMed ID: 28012867
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting Dopamine D
    Lewis MH; Primiani CT; Muehlmann AM
    J Pharmacol Exp Ther; 2019 Apr; 369(1):88-97. PubMed ID: 30745415
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: a hypothesis that may explain behavioral sensitization to psychostimulants and schizophrenia.
    Tsai SJ
    Med Hypotheses; 2005; 64(1):197-200. PubMed ID: 15533641
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Invertebrate models of drug abuse.
    Wolf FW; Heberlein U
    J Neurobiol; 2003 Jan; 54(1):161-78. PubMed ID: 12486703
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
    Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
    Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epigenetic pharmacotherapy for substance use disorder.
    Sartor GC
    Biochem Pharmacol; 2019 Oct; 168():269-274. PubMed ID: 31306644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.
    Navarro G; Carriba P; Gandía J; Ciruela F; Casadó V; Cortés A; Mallol J; Canela EI; Lluis C; Franco R
    ScientificWorldJournal; 2008 Oct; 8():1088-97. PubMed ID: 18956124
    [TBL] [Abstract][Full Text] [Related]  

  • 79. mGlu5 and adenosine A2A receptor interactions regulate the conditioned effects of cocaine.
    Brown RM; Duncan JR; Stagnitti MR; Ledent C; Lawrence AJ
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):995-1001. PubMed ID: 21816123
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models.
    Müller TE; Fontana BD; Bertoncello KT; Franscescon F; Mezzomo NJ; Canzian J; Stefanello FV; Parker MO; Gerlai R; Rosemberg DB
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109873. PubMed ID: 31981718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.